Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Parkinson's disease and reproductive life events.
Martignoni E, Nappi RE, Citterio A, Calandrella D, Corengia E, Fignon A, Zangaglia R, Riboldazzi G, Pacchetti C, Nappi G. Martignoni E, et al. Among authors: riboldazzi g. Neurol Sci. 2002 Sep;23 Suppl 2:S85-6. doi: 10.1007/s100720200082. Neurol Sci. 2002. PMID: 12548356
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease.
Blandini F, Nappi G, Fancellu R, Mangiagalli A, Samuele A, Riboldazzi G, Calandrella D, Pacchetti C, Bono G, Martignoni E. Blandini F, et al. Among authors: riboldazzi g. J Neural Transm (Vienna). 2003 Aug;110(8):911-22. doi: 10.1007/s00702-003-0004-z. J Neural Transm (Vienna). 2003. PMID: 12898346
Reproductive life milestones in women with Parkinson's disease.
Martignoni E, Nappi RE, Citterio A, Calandrella D, Zangaglia R, Mancini F, Corengia E, Riboldazzi G, Polatti F, Nappi G. Martignoni E, et al. Among authors: riboldazzi g. Funct Neurol. 2003 Oct-Dec;18(4):211-7. Funct Neurol. 2003. PMID: 15055746
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment.
Blandini F, Cosentino M, Mangiagalli A, Marino F, Samuele A, Rasini E, Fancellu R, Tassorelli C, Pacchetti C, Martignoni E, Riboldazzi G, Calandrella D, Lecchini S, Frigo G, Nappi G. Blandini F, et al. Among authors: riboldazzi g. J Neural Transm (Vienna). 2004 Aug;111(8):1017-30. doi: 10.1007/s00702-004-0123-1. Epub 2004 Mar 19. J Neural Transm (Vienna). 2004. PMID: 15254790 Clinical Trial.
52 results